| REZOLUTE INC. NEW DL-,001 |
| USA |
| Gesundheit |
| US76200L3096 / A2QEWP |
| 6HV1 (Frankfurt) / RZLT (NASDAQ) |
| FRA:6HV1, ETR:6HV1, 6HV1:GR, NASDAQ:RZLT |
| - |
| https://rezolutebio.com/ |
|
Rezolute, Inc. is a clinical-stage biopharmaceutic..
>Volltext.. |
| 780.55 Mio. EUR |
| 652.91 Mio. EUR |
| - |
| -70.71 Mio. EUR |
| -65.96 Mio. EUR |
| -0.79 EUR |
| 1.24 Mio. EUR |
| 7.78 Mio. EUR |
| -60.24 Mio. EUR |
| 14.91 |
| - |
| -5.66% |
| - |
| - |
| - |
| - |
| REZOLUTE |
| 12.12.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|